
Pasirinkite etiketę
rodoma tiesiai ant flakonoCerebrolysin
Cognition
- Siunčiame iš Vokietijos
Užsakymas
- DHL su sekimu
- Diskreti pakuotė
Trumpai
Cerebrolysin skaičiais
Pagrindiniai rodikliai iš mūsų žinyno.
Visas žinyno įrašas- Class
- Neurotrophic peptide mixturebrain extract
- Form
- Lyophilisate, 60mg/vial6-pack = 360mg
- Sizes
- 60mg/6vials1 size in the shop
What studies show
All 2 sources in the lexiconRandomized study in acute ischemic stroke (CASTA) (opens in a new tab)
Heiss et al., Stroke, 2012Cochrane review on vascular dementia (opens in a new tab)
Cui et al., Cochrane Database of Systematic Reviews, 2019
Produktui Cerebrolysin laboratorinės analizės dar nėra. Balsuoti už taiUžsakykite tyrimą, mes apmokame pusęVisos laboratorinės analizės
Žinios
Viskas apie Cerebrolysin
Išsami informacija netrukus.
Dozavimas
Įkeliama dozavimo informacija …
Pravers
Ko dar jums reikės
Bakteriostatinis vanduo į krepšelį pridedamas automatiškai. Švirkštai ir servetėlės - vienu paspaudimu.
Insulino švirkštai
10 vnt. · 5.50 €
Spiritinės servetėlės
50 vnt. · 10 €
Kiek vandens?
Vienetai ant švirkšto jūsų flakono dydžiui.
Atidaryti skaičiuoklę →Is Cerebrolysin approved?
A Cochrane review describes Cerebrolysin as widely used for stroke in Russia, Eastern Europe, China and other Asian countries. Many of the manufacturer's trials are registered as phase 4. This powder is a research product, the trials used the ready-made liquid solution.
What is in Cerebrolysin?
A mixture made in a standardised process from small peptides under 10 kDa and free amino acids from pig brain. It has no single receptor but is meant to act like the body's own nerve growth factors.
What did the large stroke trial CASTA show?
1,070 people with acute stroke received Cerebrolysin or saline for 10 days. There was no difference on the primary endpoint. In severely affected patients a post hoc analysis showed 10.5 percent deaths with Cerebrolysin and 20.2 percent with placebo. The authors see this as a signal that still needs confirmation.
What is known in vascular dementia?
A Cochrane review with six trials and 597 participants found a benefit for thinking and overall condition. The evidence is very low certainty though, the trials are at high risk of bias and, where known, were supported by the manufacturer. The authors think the effect may be too small to matter in daily life.
Does it help recovery after stroke or brain injury?
In the CARS trial with rehab over 21 days arm function after 90 days was clearly better than on placebo, but the trial was small and exploratory. After moderate to severe brain injury CAPTAIN II found a small to medium advantage across many measures. Both need to be confirmed in larger trials.
Which side effects are known?
In acute stroke Cerebrolysin changed neither mortality nor the number of all serious adverse events according to the Cochrane review, but non-fatal serious adverse events were more common than on placebo (relative risk 2.39). In an Alzheimer's trial agitation, dizziness and headache were common.
Do the trials transfer to this product?
Only to a limited extent. In the trials the ready-made liquid solution was given as an infusion into a vein, over some days to weeks. This product is a freeze-dried powder that the entry describes for subcutaneous or intramuscular use. There are no data on this form.
Susiję
Susiję produktai
Selank
Peptidai · Pažinimas ir miegas Pažinimas ir miegas
Dydžių: 3
Patikrinta laboratorijoje
= nuo 10 €/flakonas
Selank Nasal
Peptidai · Pažinimas ir miegas Pažinimas ir miegas
1 dydis
Semax
Peptidai · Pažinimas ir miegas Pažinimas ir miegas
Dydžių: 3
Patikrinta laboratorijoje
= nuo 10 €/flakonas
Semax Nasal
Peptidai · Pažinimas ir miegas Pažinimas ir miegas
1 dydis
Cerebrolysin